<VariationArchive VariationID="265121" VariationName="NM_000501.4(ELN):c.2058del (p.Gly688fs)" VariationType="Deletion" Accession="VCV000265121" Version="5" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-29" DateCreated="2016-10-10" MostRecentSubmission="2023-11-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="259874" VariationID="265121">
      <GeneList>
        <Gene Symbol="ELN" FullName="elastin" GeneID="2006" HGNC_ID="HGNC:3327" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="74028173" stop="74069907" display_start="74028173" display_stop="74069907" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="73442426" stop="73484236" display_start="73442426" display_stop="73484236" Strand="+" />
          </Location>
          <OMIM>130160</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ELN">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ELN">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000501.4(ELN):c.2058del (p.Gly688fs)</Name>
      <CanonicalSPDI>NC_000007.14:74065968:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="74065969" stop="74065969" display_start="74065969" display_stop="74065969" variantLength="1" positionVCF="74065968" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="73480299" stop="73480299" display_start="73480299" display_stop="73480299" variantLength="1" positionVCF="73480298" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G664fs</ProteinChange>
      <ProteinChange>G669fs</ProteinChange>
      <ProteinChange>G678fs</ProteinChange>
      <ProteinChange>G688fs</ProteinChange>
      <ProteinChange>G750fs</ProteinChange>
      <ProteinChange>G607fs</ProteinChange>
      <ProteinChange>G694fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.73480299del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.73480299del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.74065969del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.74065969del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009261.1" sequenceAccession="NG_009261" sequenceVersion="1" change="g.42873del">
            <Expression>NG_009261.1:g.42873del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000501.4" sequenceAccession="NM_000501" sequenceVersion="4" change="c.2058del" MANESelect="true">
            <Expression>NM_000501.4:c.2058del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000492.2" sequenceAccession="NP_000492" sequenceVersion="2" change="p.Gly688fs">
            <Expression>NP_000492.2:p.Gly688fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001081755.3" sequenceAccession="NM_001081755" sequenceVersion="3" change="c.2001del">
            <Expression>NM_001081755.3:c.2001del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001075224.1" sequenceAccession="NP_001075224" sequenceVersion="1" change="p.Gly669fs">
            <Expression>NP_001075224.1:p.Gly669fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278913.2" sequenceAccession="NM_001278913" sequenceVersion="2" change="c.1815del">
            <Expression>NM_001278913.2:c.1815del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001265842.1" sequenceAccession="NP_001265842" sequenceVersion="1" change="p.Gly607fs">
            <Expression>NP_001265842.1:p.Gly607fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278914.2" sequenceAccession="NM_001278914" sequenceVersion="2" change="c.1986del">
            <Expression>NM_001278914.2:c.1986del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001265843.1" sequenceAccession="NP_001265843" sequenceVersion="1" change="p.Gly664fs">
            <Expression>NP_001265843.1:p.Gly664fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278915.2" sequenceAccession="NM_001278915" sequenceVersion="2" change="c.2076del">
            <Expression>NM_001278915.2:c.2076del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001265844.1" sequenceAccession="NP_001265844" sequenceVersion="1" change="p.Gly694fs">
            <Expression>NP_001265844.1:p.Gly694fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278917.2" sequenceAccession="NM_001278917" sequenceVersion="2" change="c.2028del">
            <Expression>NM_001278917.2:c.2028del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001265846.1" sequenceAccession="NP_001265846" sequenceVersion="1" change="p.Gly678fs">
            <Expression>NP_001265846.1:p.Gly678fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278939.2" sequenceAccession="NM_001278939" sequenceVersion="2" change="c.2244del">
            <Expression>NM_001278939.2:c.2244del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001265868.1" sequenceAccession="NP_001265868" sequenceVersion="1" change="p.Gly750fs">
            <Expression>NP_001265868.1:p.Gly750fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001081754.3" sequenceAccession="NM_001081754" sequenceVersion="3" change="c.2047+237del">
            <Expression>NM_001081754.3:c.2047+237del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001081753.3" sequenceAccession="NM_001081753" sequenceVersion="3" change="c.1990+237del">
            <Expression>NM_001081753.3:c.1990+237del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278912.2" sequenceAccession="NM_001278912" sequenceVersion="2" change="c.2032+237del">
            <Expression>NM_001278912.2:c.2032+237del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278916.2" sequenceAccession="NM_001278916" sequenceVersion="2" change="c.1888+237del">
            <Expression>NM_001278916.2:c.1888+237del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001081752.3" sequenceAccession="NM_001081752" sequenceVersion="3" change="c.1945+237del">
            <Expression>NM_001081752.3:c.1945+237del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278918.2" sequenceAccession="NM_001278918" sequenceVersion="2" change="c.1765+237del">
            <Expression>NM_001278918.2:c.1765+237del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000501.3" sequenceAccession="NM_000501" sequenceVersion="3" change="c.2058delA">
            <Expression>NM_000501.3:c.2058delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10588435" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="130160.0009" DB="OMIM" />
        <XRef Type="rs" ID="886039351" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000501.4(ELN):c.2058del (p.Gly688fs) AND not provided" Accession="RCV000255995" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-02-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000501.4(ELN):c.2058del (p.Gly688fs) AND Supravalvar aortic stenosis" Accession="RCV001375937" Version="1">
        <ClassifiedConditionList TraitSetID="5484">
          <ClassifiedCondition DB="MedGen" ID="C0003499">Supravalvar aortic stenosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-04-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000501.4(ELN):c.2058del (p.Gly688fs) AND Cutis laxa, autosomal dominant 1" Accession="RCV002282092" Version="1">
        <ClassifiedConditionList TraitSetID="1530">
          <ClassifiedCondition DB="MedGen" ID="C3276539">Cutis laxa, autosomal dominant 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1998-06-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000501.4(ELN):c.2058del (p.Gly688fs) AND ELN-related disorder" Accession="RCV004529455" Version="1">
        <ClassifiedConditionList TraitSetID="45166">
          <ClassifiedCondition>ELN-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-03" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2016-10-10" MostRecentSubmission="2023-11-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9580666</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5484" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6013" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Supravalvar aortic stenosis</ElementValue>
                <XRef ID="Aortic+Supravalvular+Stenosis/538" DB="Genetic Alliance" />
                <XRef ID="268185002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Supravalvar aortic stenosis, Eisenberg type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SVAS</ElementValue>
                <XRef Type="MIM" ID="185500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="743" />
                <XRef ID="743" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="3193" DB="Orphanet" />
              <XRef ID="C0003499" DB="MedGen" />
              <XRef ID="MONDO:0008504" DB="MONDO" />
              <XRef Type="MIM" ID="185500" DB="OMIM" />
              <XRef Type="primary" ID="HP:0004381" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="45166" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="40852" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">ELN-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1530" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1692" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cutis laxa, autosomal dominant 1</ElementValue>
                <XRef ID="MONDO:0007411" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ADCL1</ElementValue>
                <XRef Type="MIM" ID="123700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism">Dominant Negative</Attribute>
                <XRef ID="GTR000325335" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">FBLN5-related cutis laxa is characterized by cutis laxa, early childhood-onset pulmonary emphysema, peripheral pulmonary artery stenosis, and other evidence of a generalized connective disorder such as inguinal hernias and hollow viscus diverticula (e.g., intestine, bladder). Occasionally, supravalvar aortic stenosis is observed. Intrafamilial variability in age of onset is observed. Cardiorespiratory failure from complications of pulmonary emphysema (respiratory or cardiac insufficiency) is the most common cause of death.</Attribute>
                <XRef ID="NBK5201" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15055" />
                <XRef ID="15055" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301756</ID>
                <ID Source="BookShelf">NBK5201</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36173875</ID>
                <ID Source="BookShelf">NBK584550</ID>
              </Citation>
              <XRef ID="90348" DB="Orphanet" />
              <XRef ID="C3276539" DB="MedGen" />
              <XRef ID="MONDO:0007411" DB="MONDO" />
              <XRef Type="MIM" ID="123700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38490" SubmissionDate="2012-03-15" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="130160.0009_CUTIS LAXA, AUTOSOMAL DOMINANT 1" title="ELN, 1-BP DEL, 748A_CUTIS LAXA, AUTOSOMAL DOMINANT 1" />
        <ClinVarAccession Accession="SCV000038490" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 37-year-old Caucasian patient with autosomal dominant cutis laxa (123700), Tassabehji et al. (1998) identified heterozygosity for a frameshift mutation in exon 32 of the elastin gene which was predicted to replace 37 amino acids at the C terminus of elastin by a novel sequence of 62 amino acids. Immunoprecipitation studies and mRNA showed that the mutant allele was expressed. Electron microscopy of the skin sections showed abnormal branching and fragmentation in the amorphous elastin component, and immunocytochemistry showed reduced elastin deposition in the elastic fibers and fewer microfibrils in the dermis. These findings suggested that the mutant tropoelastin protein was synthesized, secreted, and incorporated into the elastic matrix, where it altered the architecture of elastic fibers. Interference with crosslinking would reduce elastic recoil in affected tissues and explain the cutis laxa phenotype.</Attribute>
              <Citation>
                <ID Source="PubMed">9580666</ID>
              </Citation>
              <XRef DB="OMIM" ID="123700" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ELN" />
          </GeneList>
          <Name>ELN, 1-BP DEL, 748A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 748A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="130160.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CUTIS LAXA, AUTOSOMAL DOMINANT 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="616254" SubmissionDate="2019-01-29" DateLastUpdated="2016-10-10" DateCreated="2016-10-10">
        <ClinVarSubmissionID localKey="GDX:19572|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000321601" DateUpdated="2016-10-10" DateCreated="2016-10-10" Type="SCV" Version="7" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-02-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.2058delA pathogenic variant in the ELN gene, also reported as c.2262delA due to alternative nomenclature, has been reported previously in association with cutis laxa (Tassabehji et al., 1998; Hadj-Rabia et al., 2013). The c.2058delA variant causes a frameshift starting with codon Glycine 688, changes this amino acid to a Valine residue, and creates a premature Stop codon at position 63 of the new reading frame, denoted p.Gly688ValfsX63. This frameshift variant replaces the typical last 37 amino acid residues in the ELN protein with 62 incorrect amino acid residues and may result in a protein with altered structure or function. The c.2058delA variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.2058delA as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ELN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000501.2:c.2058delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3097151" SubmissionDate="2021-03-31" DateLastUpdated="2021-05-05" DateCreated="2021-05-05">
        <ClinVarSubmissionID localKey="UCSF544|OMIM:185500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001572920" DateUpdated="2021-05-05" DateCreated="2021-05-05" Type="SCV" Version="1" SubmitterName="Genomic Medicine Lab, University of California San Francisco" OrgID="506696" OrganizationCategory="laboratory" OrgAbbreviation="UCSF GML" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-04-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Exome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ELN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000501.4:c.2058del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="185500" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-P3EGS</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9397059</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7684719" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="35233182|ELN-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004112172" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The ELN c.2058delA variant is predicted to result in a frameshift and premature protein termination (p.Gly688Valfs*63). This variant has been reported in many individuals and families with autosomal dominant cutis laxa (Reported as delA in codon 748 in Tassabehji M et al 1998. PubMed ID: 9580666; Reported as c.2262del in Hadj-Rabia. 2013. PubMed ID: 23442826 ). Of note, this variant can also be referred to as c.2244delA (p.Gly750Valfs*63) with an alternative transcript, NM_001278939. This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in ELN are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ELN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000501.3:c.2058delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ELN-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3097151" TraitType="Disease" MappingType="XRef" MappingValue="185500" MappingRef="OMIM">
        <MedGen CUI="C0003499" Name="Supravalvar aortic stenosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="616254" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="38490" TraitType="Disease" MappingType="Name" MappingValue="CUTIS LAXA, AUTOSOMAL DOMINANT 1" MappingRef="Preferred">
        <MedGen CUI="C3276539" Name="Cutis laxa, autosomal dominant 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7684719" TraitType="Disease" MappingType="Name" MappingValue="ELN-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="ELN-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

